Preparing for EOFY: must-do actions before 30 June
The end of the financial year (EOFY) is fast approaching, and as a pharmacy owner, ensuring you wrap up the year efficiently is key to setting your business up for …
Simple steps to boost your online visibility
Can your community pharmacy appear at the top of the local online search rankings? Easily, if you know the rules, according to Carl Jones from Local Manager Around 46% of …
Twice the work, half the respect
Pharmacy must close its cultural safety gap… and here’s why, writes Mohamed Yousef Forbidden aisles Australia’s health system prides itself on quality and inclusivity, yet bias and discrimination persist. These …
May MIMS update
Some of the recent changes to the medicines landscape, with new products, indications, contraindications, presentations and safety related changes New Products Dexrazoxane (Dexrazoxane-Reach) is an analogue of ethylene diamine tetra-acetic …
Thriving in a competitive market: leaning into your pharmacy’s strengths
The conversation about standing out in a competitive pharmacy landscape is not a new one, writes Peak Strategies’ marketing coordinator, Rebecca Goodsell We’ve discussed it in many forms, but …
The role of community pharmacy has never been more vital in our health system
With Australia’s health system facing a range of challenges, the expansion for pharmacists’ scope of practice is enabling the profession to play a key role, writes Pharmacy 777 managing director, …
Understanding fringe benefits tax
Navigating the world of tax obligations can be complex, and one area that often catches business owners by surprise is fringe benefits tax (FBT), Victoria Le senior manager, compliance and …
The future of healthcare depends on how we learn together
There was a time when a white coat or a title was enough for people to trust us—but is that still true today? asks Bronwyn Clark The healthcare landscape is …
April MIMS update
Some of the recent changes to the medicines landscape, with new products, indications and contraindications New Products Momelotinib (as dihydrochloride monohydrate) (Omjjara) and its major circulating metabolite (M21) are inhibitors …
Mixed news on tariffs
Pharma not entirely insulated from Trump’s tariff plans despite an initial strong market reaction, says Mike Taylor It says a great deal about investor perceptions of the relative safety of …
Budget 2025: what does it mean for pharmacy?
Here’s what you need to know about the recent federal budget, with expert analysis from the team at Peak Strategies Federal Treasurer, Jim Chalmers has unveiled the 2025-26 Federal Budget …
Budget 2025: what does it mean for health?
With an election looming, NAB Health looks at what the federal budget will deliver for the sector This is clearly an election-related budget – and probably one the Government wasn’t …